HCP, Inc. (HCP) Stake Lessened by SFE Investment Counsel
SFE Investment Counsel decreased its holdings in HCP, Inc. (NYSE:HCP) by 5.5% during the 3rd quarter, according to the company in its most recent filing with the SEC. The fund owned 216,246 shares of the real estate investment trust’s stock after selling 12,660 shares during the period. HCP makes up about 2.5% of SFE Investment Counsel’s portfolio, making the stock its 11th biggest position. SFE Investment Counsel’s holdings in HCP were worth $6,018,000 at the end of the most recent quarter.
Several other institutional investors and hedge funds have also modified their holdings of HCP. FMR LLC increased its stake in shares of HCP by 2.4% in the 1st quarter. FMR LLC now owns 214,161 shares of the real estate investment trust’s stock valued at $6,699,000 after purchasing an additional 5,007 shares during the last quarter. Fox Run Management L.L.C. grew its position in HCP by 195.6% during the 2nd quarter. Fox Run Management L.L.C. now owns 47,000 shares of the real estate investment trust’s stock worth $1,502,000 after acquiring an additional 31,100 shares during the last quarter. Atria Investments LLC lifted its holdings in HCP by 1.2% during the 2nd quarter. Atria Investments LLC now owns 12,447 shares of the real estate investment trust’s stock worth $398,000 after buying an additional 147 shares during the period. Bank of Montreal Can lifted its holdings in HCP by 59.6% during the 2nd quarter. Bank of Montreal Can now owns 595,192 shares of the real estate investment trust’s stock worth $19,022,000 after buying an additional 222,258 shares during the period. Finally, Pennsylvania Trust Co acquired a new position in HCP during the 2nd quarter worth about $362,000. Institutional investors own 90.04% of the company’s stock.
HCP, Inc. (HCP) traded up $0.09 on Monday, reaching $27.24. The company had a trading volume of 584,382 shares, compared to its average volume of 3,447,487. The company has a market capitalization of $12,731.60, a PE ratio of 13.18, a PEG ratio of 2.90 and a beta of 0.36. The company has a current ratio of 0.61, a quick ratio of 0.61 and a debt-to-equity ratio of 1.17. HCP, Inc. has a 1-year low of $25.08 and a 1-year high of $33.67.
HCP (NYSE:HCP) last released its earnings results on Thursday, November 2nd. The real estate investment trust reported $0.48 EPS for the quarter, beating the Zacks’ consensus estimate of $0.46 by $0.02. The business had revenue of $454.00 million for the quarter, compared to analysts’ expectations of $440.60 million. HCP had a return on equity of 8.85% and a net margin of 27.31%. The firm’s revenue was down 14.4% on a year-over-year basis. During the same quarter in the prior year, the firm earned $0.72 earnings per share. equities research analysts predict that HCP, Inc. will post 1.93 EPS for the current year.
The business also recently disclosed a quarterly dividend, which will be paid on Tuesday, November 21st. Stockholders of record on Monday, November 6th will be paid a dividend of $0.37 per share. The ex-dividend date of this dividend is Friday, November 3rd. This represents a $1.48 dividend on an annualized basis and a dividend yield of 5.43%. HCP’s dividend payout ratio (DPR) is currently 133.33%.
Several research analysts have commented on HCP shares. Zacks Investment Research downgraded HCP from a “hold” rating to a “sell” rating in a report on Tuesday, October 3rd. Jefferies Group LLC reissued a “hold” rating and issued a $33.00 price objective on shares of HCP in a research note on Tuesday, July 25th. BMO Capital Markets reaffirmed a “hold” rating and set a $32.00 price target on shares of HCP in a research note on Wednesday, September 6th. Stifel Nicolaus reaffirmed a “hold” rating and set a $30.00 price target on shares of HCP in a research note on Wednesday, October 4th. Finally, UBS AG downgraded HCP from a “neutral” rating to a “sell” rating and dropped their price target for the stock from $30.00 to $25.00 in a research note on Monday, October 2nd. Four analysts have rated the stock with a sell rating, twelve have given a hold rating and two have issued a buy rating to the company. The stock presently has a consensus rating of “Hold” and a consensus target price of $30.98.
ILLEGAL ACTIVITY NOTICE: This news story was originally published by Watch List News and is the property of of Watch List News. If you are reading this news story on another site, it was illegally copied and republished in violation of United States and international copyright legislation. The correct version of this news story can be viewed at https://www.watchlistnews.com/hcp-inc-hcp-stake-lessened-by-sfe-investment-counsel/1683155.html.
HCP, Inc is a self-administered real estate investment trust. The Company invests in real estate serving the healthcare industry in the United States. The Company’s segments include senior housing triple-net (SH NNN), senior housing operating portfolio (SHOP), life science and medical office. Its senior housing facilities include independent living facilities, assisted living facilities, memory care facilities, care homes, and continuing care retirement communities.
Want to see what other hedge funds are holding HCP? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for HCP, Inc. (NYSE:HCP).
Receive News & Ratings for HCP Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for HCP Inc. and related companies with Analyst Ratings Network's FREE daily email newsletter.